Tyler Ostlund
Nurse Practitioner · Vineyard, UTNPI 1285335018
Payments from drug & device makers
Across 209 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Johnson & Johnson$621
- UCB, Inc.$337
- AbbVie$227
- Novartis$145
- GSK$129
- plus $597 from 11 others
What the payments were for
- Food & beverage$2,84988%
- Education$38812%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 100 | $1,180 |
| Johnson & Johnson | 22 | $621 |
| UCB, Inc. | 23 | $337 |
| AbbVie | 16 | $227 |
| Novartis | 7 | $145 |
| GSK | 8 | $129 |
| Organon | 11 | $94 |
| Boehringer Ingelheim | 4 | $91 |
| Boston Scientific | 2 | $91 |
| ANI Pharmaceuticals, Inc. | 3 | $73 |
| AstraZeneca | 3 | $66 |
| Fresenius Kabi USA, LLC | 4 | $63 |
| Sandoz | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Mylan Institutional Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $15 |
How this compares
$3,237 in reported general payments places this provider in the 90th percentile of 979 nurse practitioner providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 46 | $389,345 |
| Enbrel SureclickEtanercept | 23 | $166,588 |
| Hydroxychloroquine Sulfate | 253 | $14,264 |
| MethotrexateMethotrexate Sodium | 341 | $10,801 |
| Leflunomide | 81 | $5,152 |
| Sulfasalazine | 70 | $2,890 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 71 | $1,209 |
| Folic Acid | 91 | $1,037 |
| Prednisone | 105 | $685 |
| Leucovorin Calcium | 15 | $508 |
| Celecoxib | 14 | $413 |
| Duloxetine Hcl | 16 | $375 |
| Tramadol Hcl | 44 | $365 |
| Pregabalin | 12 | $319 |
| Gabapentin | 20 | $263 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Vineyard
- David GambleAmerican Fork$836K
- Julia BattenSalt Lake City$223K
- Stacie EganOgden$170K
- Traci AndreasonLehi$161K
- Geoffrey OsmondDraper$62K
- Trenton GraySouth Salt Lake$40K
- Kelsey FurrWest Jordan$21K
- Merin KinikiniSalt Lake City$19K
- Phillip BowmanSalt Lake City$18K
- Lynn LarsenOgden$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.